相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proteolytic processing of PD-L1 by ADAM proteases in breast cancer cells
Yeni Romero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Senescent cells: Living or dying is a matter of NK cells
Fabrizio Antonangeli et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells
Andrew M. Gravett et al.
SCIENTIFIC REPORTS (2019)
Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis
Zheng-Lin Ou et al.
RNA BIOLOGY (2019)
Cellular Senescence: Defining a Path Forward
Vassilis Gorgoulis et al.
CELL (2019)
ADAM10 mediates malignant pleural mesothelioma invasiveness
Christelle Sepult et al.
ONCOGENE (2019)
Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging
Denise P. Munoz et al.
JCI INSIGHT (2019)
Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells
Stefanie Maurer et al.
ONCOIMMUNOLOGY (2018)
Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10
Kaku Goto et al.
Oncotarget (2018)
Mica-129 Dimorphism and soluble Mica are associated With the Progression of Multiple Myeloma
Alessandra Zingoni et al.
FRONTIERS IN IMMUNOLOGY (2018)
NKG2D and Its Ligands: One for All, All for One
Alessandra Zingoni et al.
FRONTIERS IN IMMUNOLOGY (2018)
Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells
Francesca Tosetti et al.
ONCOIMMUNOLOGY (2018)
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The emerging role of ADAM metalloproteinases in immunity
Bart N. Lambrecht et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma
Chao Niu et al.
ONCOTARGET (2017)
p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells
Alessandra Soriani et al.
ONCOIMMUNOLOGY (2017)
Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma
Sandra Weil et al.
FRONTIERS IN IMMUNOLOGY (2017)
Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
Alessandra Zingoni et al.
FRONTIERS IN IMMUNOLOGY (2017)
The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA
Antje Isernhagen et al.
IMMUNOGENETICS (2016)
MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer
Riki Okita et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay
Maria Pia Abruzzese et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Endostatin and irradiation modifies the activity of ADAM10 and neprilysin in breast cancer cells
Esra Arslan Aydemir et al.
MOLECULAR MEDICINE REPORTS (2016)
SEP enhanced the antitumor activity of 5-fluorouracil by up-regulating NKG2D/MICA and reversed immune suppression via inhibiting ROS and caspase-3 in mice
Mengyun Ke et al.
ONCOTARGET (2016)
Gemcitabine promotes immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein
Xiansheng Lin et al.
ONCOTARGET (2016)
Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells
Fabrizio Antonangeli et al.
ONCOIMMUNOLOGY (2016)
Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells
Alessandra Zingoni et al.
JOURNAL OF IMMUNOLOGY (2015)
Sulforaphane induces ROS mediated induction of NKG2D ligands in human cancer cell lines and enhances susceptibility to NK cell mediated lysis
Prayag J. Amin et al.
LIFE SCIENCES (2015)
NKG2D Receptor and Its Ligands in Host Defense
Lewis L. Lanier
CANCER IMMUNOLOGY RESEARCH (2015)
Radiation-induced matrix metalloproteinases limit natural killer cell-mediated anticancer immunity in NCI-H23 lung cancer cells
Woong Heo et al.
MOLECULAR MEDICINE REPORTS (2015)
MICA polymorphism: biology and importance in cancer
Dan Chen et al.
CARCINOGENESIS (2014)
A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells
Fabian Wolpert et al.
NEURO-ONCOLOGY (2014)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008
Omodele Ashiru et al.
BIOCHEMICAL JOURNAL (2013)
Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR)
Christoph Garbers et al.
CELL CYCLE (2013)
Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the a disintegrin and metalloproteases 10 and 17
Guranda Chitadze et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications
G. Chitadze et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
Etoposide induces apoptosis and upregulation of TACE/ADAM17 and ADAM10 in an in vitro male germ cell line model
Carlos Lizama et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Hypoxia Induces Escape from Innate Immunity in Cancer Cells via Increased Expression of ADAM10: Role of Nitric Oxide
Ivraym B. Barsoum et al.
CANCER RESEARCH (2011)
Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding
Sonia Agüera-González et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of Cancer
Baocheng Huang et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes
Omodele Ashiru et al.
CANCER RESEARCH (2010)
Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal Cancer
Joan N. Kyula et al.
CLINICAL CANCER RESEARCH (2010)
Sorafenib Inhibits the Shedding of Major Histocompatibility Complex Class I-Related Chain A on Hepatocellular Carcinoma Cells by Down-Regulating a Disintegrin and Metalloproteinase 9
Keisuke Kohga et al.
HEPATOLOGY (2010)
Cutting Edge: The Membrane Type Matrix Metalloproteinase MMP14 Mediates Constitutive Shedding of MHC Class I Chain-Related Molecule A Independent of A Disintegrin and Metalloproteinases
Gang Liu et al.
JOURNAL OF IMMUNOLOGY (2010)
TNF-alpha-converting enzyme (TACE/ADAM17)-dependent loss of CD30 induced by proteasome inhibition through reactive oxygen species
A. M. Vahdat et al.
LEUKEMIA (2010)
The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia
H. Nueckel et al.
LEUKEMIA (2010)
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
Alessandra Soriani et al.
BLOOD (2009)
Anticancer Chemotherapy Inhibits MHC Class I-Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
Keisuke Kohga et al.
CANCER RESEARCH (2009)
Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B
Annette Paschen et al.
CLINICAL CANCER RESEARCH (2009)
Cutting Edge: The Metalloproteinase ADAM17/TNF-α-Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein
Philippe Boutet et al.
JOURNAL OF IMMUNOLOGY (2009)
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
A. Poggi et al.
LEUKEMIA (2009)
Senescence-messaging secretome: SMS-ing cellular stress
Thomas Kuilman et al.
NATURE REVIEWS CANCER (2009)
Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: Role of nitric oxide
D. Robert Siemens et al.
CANCER RESEARCH (2008)
Tumor-associated MICA is shed by ADAM proteases
Inja Waldhauer et al.
CANCER RESEARCH (2008)
The ADAM metalloproteinases
Dylan R. Edwards et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma
Masahisa Jinushi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
ADAMs in cancer cell proliferation and progression
Satsuki Mochizuki et al.
CANCER SCIENCE (2007)
Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients
Vera Rebmann et al.
CLINICAL IMMUNOLOGY (2007)
Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma
Shun-Yao Ko et al.
CANCER LETTERS (2007)
ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro
Dennis A. Eichenauer et al.
CANCER RESEARCH (2007)
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA
Stefan Holdenrieder et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Proteolytic release of soluble UL16-binding protein 2 from tumor cells
I Waldhauer et al.
CANCER RESEARCH (2006)
Soluble MICA in malignant diseases
S Holdenrieder et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D Ligands by the histone deacetylase inhibitor sodium valproate
S Armeanu et al.
CANCER RESEARCH (2005)
ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and, β-catenin translocation
T Maretzky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and β-catenin nuclear signalling
K Reiss et al.
EMBO JOURNAL (2005)
L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers
N Gavert et al.
JOURNAL OF CELL BIOLOGY (2005)
Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP
DR McCulloch et al.
CLINICAL CANCER RESEARCH (2004)
Oxidative and osmotic stress signaling in tumor cells is mediated by ADAM proteases and heparin-binding epidermal growth factor
OM Fischer et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas
M Fogel et al.
LANCET (2003)
Protein ectodomain shedding
J Arribas et al.
CHEMICAL REVIEWS (2002)
ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles
P Gutwein et al.
FASEB JOURNAL (2002)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding
HR Salih et al.
JOURNAL OF IMMUNOLOGY (2002)
Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins
S Mechtersheimer et al.
JOURNAL OF CELL BIOLOGY (2001)
Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells
P Gutwein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
